Track Sanofi — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Sanofi SANOFI.NS Open Sanofi in new tab

3196.90 INR
P/E
25.36
EPS
134.45
Yield
3.62%
Safety Score
39
P/B
10.48
ROE
40.59
Beta
0.23
Target Price
4579.00 INR
Loading chart...
Key Metrics
Earnings dateJuly 28, 2026
P/E25.36
EPS134.45
Book Value325.31
Price to Book10.48
Debt/Equity2.38
% Insiders60.601%
Growth
Revenue Growth-0.12%
Earnings Growth-0.14%
Estimates
Forward P/E19.04
Forward EPS179.07
Target Mean Price4579.00
Dividend
Dividend Yield3.62%
Annual dividends123.00 INR
Ex-Div. DateApril 22, 2026
Payout86.99%
5y avg Yield2.64%

DCF Valuation

Tweak assumptions to recompute fair value for Sanofi (SANOFI.NS)
Currency: INR
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
Current Price
Upside
WACC
Terminal PV
Σ PV of FCFs
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Sanofi Logo Sanofi Analysis (SANOFI.NS)

France Health Care Official Website Stock

Is Sanofi a good investment? Sanofi (SANOFI.NS) is currently trading at 3196.90 INR. Market analysts have a consensus price target of 4579.00 INR. This suggests a potential upside from current levels.

In terms of valuation, the stock trades at a P/E ratio of 25.36. This valuation is generally in line with the broader market.

Earnings Schedule: Sanofi is expected to release its next earnings report on July 28, 2026. The market consensus estimate for Forward EPS is 179.07.

For income investors, Sanofi pays a dividend yield of 3.62%. With a payout ratio of 87%, the dividend appears to be under pressure.

Investor FAQ

Does Sanofi pay a dividend?

Yes, it pays an annual dividend of 123.00 INR (3.62% yield).

What asset class is Sanofi?

Sanofi is classified as a Stock. You can compare it against 2 other assets in the "Related Symbols" list on this page.

When is the next earnings date?

The next earnings date is projected to be July 28, 2026. The company currently has a trailing EPS of 134.45.

Company Profile

Sanofi India Limited manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally. The company provides pharmaceutical products in various therapeutic areas, such as diabetes, cardiology, thrombosis, infections, epilepsy, anti-infectives, and central nervous system, as well as allergy, pain care, digestive, and nutritional health under the Lantus, Toujeo, Soliqua, Clexane, Amaryl, Cardace, Lasix, Lasilactone, Glimepiride, Cetapin, Targocid, Frisium, Targocio, Combiflam, DePura, Allegra, Baralgan, BUSCOGAST, Dulcoflex, Enterogermina, Novalgin, and Avil brands through independent distributors. It also exports its products to approximately 24 countries. The company was formerly known as Aventis Pharma Limited and changed its name to Sanofi India Limited in May 2012. The company was incorporated in 1956 and is headquartered in Mumbai, India. Sanofi India Limited is a subsidiary of Hoechst GmbH.

Exchange Ticker
NSI (India) SANOFI.NS
BSE (India) SANOFI.BO
Dividend Yield

3.62% (5y avg: 2.64%)

Annual Dividends

123.00 INR

Next ex. div date

April 22, 2026

Payout Ratio

86.99%

Historical Dividends
Year Total Dividends
2026 240.00 INR
2025 192.00 INR
2024 167.00 INR
2023 183.00 INR
2022 374.00 INR
2021 240.00 INR
2020 349.00 INR
2019 66.00 INR
2018 71.00 INR
2017 68.00 INR
2016 43.00 INR
2015 42.00 INR
2014 45.00 INR
2013 39.00 INR
2012 33.00 INR
2011 27.00 INR
2010 20.50 INR
2009 16.00 INR
2008 16.00 INR
2007 32.00 INR
2006 16.00 INR
2005 16.00 INR
2004 16.00 INR
2003 17.00 INR

Yearly aggregated dividends

Dividends

Sanofi
May 28, 2026 Upcoming
Dividend
48.0 INR
Sanofi
Nov 28, 2025 Paid
Dividend
75.0 INR

Historical Split Corporate Actions

Trades
Trade History
No trades yet
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion